Jamie Paterson, CEO

Jamie Paterson, a British national, has over 20 years of experience in the pharmaceutical industry. Prior to joining Viroblock he was Chief Commercial Officer at Neurim Pharmaceuticals. During his 18 years at Procter & Gamble he held several positions with increasing responsibility including Marketing Manager Italy and Commercial Director Spain. His final position at P&G was European Director of Strategic Planning and New Business Development – Rx & OTC. Jamie holds a PhD in Biochemistry from Imperial College, University of London.

Thierry Pelet, CSO

Of scientific background, Thierry worked for many years in the virology field on topics including molecular determinant of viral replication, viral pathogenesis and budding process. He obtained its PhD in molecular virology in 1996 at the University of Geneva. He then performed his post-doctoral studies at the Clinical Research Institute in Montreal, Canada. Back to Switzerland, he worked as a senior scientist in several virology laboratories. His publications include more than a dozen of scientific papers in peer-reviewed virology journals. Thierry is a co-founder of Viroblock and was the CEO of the company until 2010.